Success Story: NIW Approved Without RFE! We Helped a Postdoctoral Research Fellow Secure Success
Client’s Testimonial:
"I am incredibly grateful for the outstanding legal support from the Wegreened team. What stood out to me was their unique and personalized approach. They didn't just see me as another case with a low citation number and no recommendation letters. Instead, they took the time to understand the nuances of my research, skillfully highlighting my patent and the NIH-funded nature of my work to connect my endeavor to the national interest. This tailored strategy was instrumental in my case, being approved without an RFE. I wholeheartedly recommend their services to anyone seeking an expert team that is not only highly competent but also genuinely invested in their clients' success."
On May 27th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Bioengineering (Approval Notice).
General Field: Bioengineering
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Taiwan
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: May 27th, 2026
Processing Time: 10 months, 16 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share that the client, a bioengineering researcher with a Ph.D. in bioengineering, secured I-140 NIW approval for her work in precision cancer treatment. As an expert in bioengineering, the client’s proposed endeavor focuses on developing advanced treatments and improving the efficacy of photodynamic therapy by combining immunological antibody platforms and chemotherapies with personalized real-time dosage feedback systems. Her research aims to address treatment-resistant ovarian cancer and hepatocellular carcinoma while advancing precision medicine.
To show that the client was well-positioned to advance this endeavor, we highlighted her research record, including:
- 4 peer-reviewed journal articles, including 3 first- or co-first-authored articles
- 4 conference abstracts, including 1 first-authored abstract
- 1 patent application publication
- 35 total citations to her published work
- The National Institutes of Health (NIH)-funding support for research connected to the national interest
These metrics were not presented as self-sufficient proof. Rather, the petition explained how an adjudicator could view the client’s publication record, citation history, and patent-related work as evidence that her methods had attracted independent attention and practical interest in the field. The 35 citations showed that other researchers had used her findings in work involving photosensitizer delivery, photodynamic therapy, photoimmunotherapy, nanotechnology, and tumor treatment methods. Although the provided record did not identify a peer-review service count, the petition relied on other objective indicators, including publication placement, citation performance, patent activity, and funding, to demonstrate professional significance.
Ultimately, the petition showed that the client’s advanced education, specialized research agenda, publication record, citation impact, patent-related contribution, and NIH-supported work collectively established her ability to continue advancing nationally important bioengineering research. We congratulate the client on this I-140 NIW approval and wish her continued success in developing innovative cancer treatment technologies.